Announced the proposed issue of 8.0 million in convertible loan notes, subject to shareholder approval (see separate release issued today) Secured $1.8 million in debt with Republic First Bank to finance Food Safety System lease installations Received a new US FDA 510(k) clearance for over-the-counter (OTC) marketing for Vashe Wound Therapy Renewed PuriCore Endoscopy's distribution agreement with Minntech, a wholly owned subsidiary of Cantel Medical (NYSE: CMN)

A complete business report for the quarter is available PuriCore's website.

Greg Bosch, PuriCore CEO, said:

"PuriCore has started the year with Q1 in line with Directors' expectations. With our successful fund raising, we remain on track to execute our business strategies for 2010."

SOURCE PuriCore plc